Search clinical trials for: SyB P-1501 placebo

Total 1991 results

AstraZeneca

Active, not recruiting

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study (SUPERNOVA)

COVID-19, SARS-CoV-2

United States, Belgium, Canada, France, Spain, Denmark, Thailand, Vietnam, Korea, Republic of, United Kingdom, Malaysia, Israel, Taiwan, Australia, Germany, Poland, Singapore, United Arab Emirates
Corcept Therapeutics

Completed

Single and Multiple Dose Study of Miricorilant (CORT118335) Tablet Formulations in Healthy Participants

Healthy

United Kingdom
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Terminated

Abituzumab in SSc-ILD

Systemic Sclerosis-associated Interstitial Lung Disease

United States, Canada, Italy, Poland, Spain, Argentina, Australia, Israel, United Kingdom
University of South Florida
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria

Arthritis, Reactive | Reiter Disease

United States, Canada
Merck Sharp & Dohme LLC

Completed

A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)

HIV Infections
Aziende Chimiche Riunite Angelini Francesco S.p.A
Cross Research S.A.

Completed

Tolerability and Pharmacokinetic Study of Econazole Nitrate Plus Benzydamine HCl Vaginal Pessary

Healthy Women

Switzerland
VistaGen Therapeutics, Inc.

Not yet recruiting

AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia

Parkinson Disease | Dyskinesia, Medication-Induced | L-Dopa Causing Adverse Effects in Therapeutic Use
Oxford Cannabinoid Technologies Holdings PLC
Simbec-Orion Group

Completed

Single Ascending Oral Dose Study to Investigate the Effects of OCT461201 in Healthy Volunteers

Healthy

United Kingdom
Rigel Pharmaceuticals

Completed

Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy

IGA Nephropathy

United States, United Kingdom, Hong Kong, Taiwan, Austria, Germany
Jazz Pharmaceuticals

Completed

A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)

Epilepsy | Dravet Syndrome

United States, United Kingdom
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Bupropion-Enhanced Contingency Management (CM) for Cocaine Dependence

Substance Abuse | Cocaine Dependence

United States
NeuroBo Pharmaceuticals Inc.

Completed

Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides

Hypercholesterolemia | Hypertriglyceridemia
Provident Clinical Research
GlaxoSmithKline

Completed

Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia

Primary Hypercholesterolemia

United States
Novartis Pharmaceuticals

Completed

Assess Bronchodilator Effect QVM149 Dosed Either in the Morning or Evening Compared to Placebo in Patients With Asthma (QVM149)

Asthma

Germany, Netherlands, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Assessment of LBR-101 In Chronic Migraine

Chronic Migraine

United States
Herlev Hospital

Terminated

Treatment of Post Stroke Fatigue With a Wakefulness Promoting Agent

Stroke | Post Stroke Fatigue

Denmark
Kinevant Sciences GmbH

Completed

Phase 1 Study With KIN-1901 in Healthy Subjects and Subjects With Ankylosing Spondylitis

Inflammation | Rheumatic Diseases

Canada
University of Sao Paulo

Completed

Non-carious Cervical Lesions and Treatments (NCCL)

Tooth Sensitivity

Brazil
University of Manitoba
Manitoba Medical Service Foundation; Research Manitoba

Recruiting

Vulvovaginal Candidiasis in Canadian Females (THRIVE-yeast)

Candidiasis, Vulvovaginal

Canada
University of Oulu

Completed

Pregnane X Receptor (PXR) Agonist Rifampicin Effects on Glucose, Lipid and Hormone Homeostasis

Glucose Tolerance

Finland
Neuramedy Co. Ltd.
Quotient Sciences

Not yet recruiting

Single and Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of NM-101

Parkinson Disease

United Kingdom
Eisai Inc.

Completed

Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003

Idiopathic Thrombocytopenic Purpura

United States
Galapagos NV

Completed

A Study to Evaluate GLPG2222 in Ivacaftor-treated Subjects With Cystic Fibrosis

Cystic Fibrosis

Ireland, United Kingdom, Belgium, Australia, Czechia, Germany
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed Conditions

Healthy

United States
Institut Pasteur
Assistance Publique Hopitaux De Marseille; Ministry of Health, France; Hôpital... and other collaborators

Not yet recruiting

Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients (ABCESS2)

Hidradenitis Suppurativa

France
Emory University
Bristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of...

Active, not recruiting

Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Hodgkin Lymphoma | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Classical Hodgkin Lymphoma

United States
10xBio, LLC
Therapeutics, Inc.

Active, not recruiting

Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity

Subcutaneous Fat Disorder

United States
Fundación Cardioinfantil Instituto de Cardiología
Instituto de Corazón de Bucaramanga

Unknown

A Trial Testing Amiodarone in Chagas Cardiomiopathy (ATTACH)

Chagas Cardiomyopathy

Colombia
Rambam Health Care Campus

Unknown

Treatment of Postoperative Atrial Fibrillation - Comparison of Amiodarone and Placebo.

Atrial Fibrillation
Ottawa Hospital Research Institute
Heart and Stroke Foundation of Ontario

Completed

Atrial Fibrillation Without Hemodynamic Instability in the Intensive Care Unit (AFIB)

Atrial Fibrillation
Rigshospitalet, Denmark

Completed

The Effect of Short Term Amiodarone Treatment After Catheter Ablation for Atrial Fibrillation (AMIO-CAT)

Atrial Fibrillation

Denmark
Yuria-Pharm

Terminated

Efficacy and Safety of Intravenous Treatment of Tuberculosis

Tuberculosis, Pulmonary

Ukraine
GlaxoSmithKline

Completed

A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors

Cancer

Australia, United States, United Kingdom
Cambridge University Hospitals NHS Foundation Trust

Completed

Neurochemical Modulation Cognitive Performance and Subjective Wellbeing In Healthy Controls (ModCog)

Healthy Volunteers | Motivation | Cognitive Performance | Reward | Creativity | Subjective Pleasure

United Kingdom
Novartis Pharmaceuticals

Completed

4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

Moderate to Severe Chronic Plaque-Type Psoriasis

United States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
Cumberland Pharmaceuticals

Recruiting

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

Pathologic Processes | Skin Diseases | Autoimmune Diseases | Connective Tissue Diseases | Scleroderma, Systemic | Scleroderma, Diffuse | Scleroderma, Limited | Sclerosis, Progressive Systemic

United States, India
Grünenthal GmbH

Completed

A Clinical Study in Healthy Subjects Which Aims to Investigate the Safety, the Tolerability and the Effects of GRT0151Y and How the Compound is Taken up and Excreted From the Body

Acute Pain

France
Institute for Atherosclerosis Research, Russia

Not yet recruiting

The Effects of Allicor on Patients After Revascularization Treatment During a Year (TEA-PARTY)

Peripheral Arterial Disease | Atherosclerosis

Russian Federation
Kirby Institute

Completed

Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naïve Adults. (ENCORE1)

HIV Infections

Australia
Samyang Biopharmaceuticals Corporation

Completed

Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend)

Systemic Mycotic Infection

Korea, Republic of
University of Washington
National Cancer Institute (NCI)

Completed

Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma (TREC)

Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Hodgkin Lymphoma

United States
Future Medicine

Recruiting

FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis

Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis

Spain, Hungary, Poland
Upstream Bio Inc.

Completed

Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in Asthmatics

Asthma

United Kingdom
Skyline Biosciences

Withdrawn

This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions

Leukoplakia, Oral

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fed Conditions

Healthy

United States
University of Calgary

Recruiting

Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study (AAA)

Atrial Fibrillation

Canada
Ottawa Hospital Research Institute

Recruiting

Prophylaxis for Patients at Risk to Eliminate Post-operative Atrial Fibrillation (PREP-AF)

Atrial Fibrillation

Canada
Merck Sharp & Dohme LLC

Completed

V501 Efficacy Study in Women Aged 18 to 26 (V501-027)

HPV Infections
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults

HIV Infections

United States, Puerto Rico

Search clinical trials for: SyB P-1501 placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations